The Clinical Times
The Front Page of Medicine

Guidelines & Practice · page 6

Practice updates and recommendations from the major professional societies.

ACC (Cardiology) · Jun 29, 2026

Discontinuation of Oral Anticoagulation After AF Catheter Ablation (ALONE-AF): ALONE, but Not the Only One

The ALONE-AF (Anticoagulation One Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation) trial examined whether discontinuing oral anticoagulation (OAC) in patients with elevated stroke risk after catheter ablation of atrial fibrillation (AFCA) who remain free of atrial arrhythmias in the year after their indexed ablation leads to fewer adverse clinical outcomes.

MedCity News · Jun 28, 2026

The Terminology Gap Undermining Cervical Cancer Screening Guidelines

While the Pap identifies the cell changes, the HPV test determines the root cause before those changes even happen. Both tests have saved lives. But they are not interchangeable, and treating them as such puts the patient at risk. The post The Terminology Gap Undermining Cervical Cancer Screening Guidelines appeared first on MedCity News .

ACC (Cardiology) · Jun 26, 2026

ERAS-Based Signaling in Cardiology Fellowship Recruitment

A recent JACC review explores the growing impact of Electronic Residency Application Service (ERAS)-based signaling in cardiology fellowship recruitment, highlighting the most recent data, areas of future investigation, and practical guidance for applicants and programs.

ACC (Cardiology) · Jun 25, 2026

HHS Releases Consumer Alert on Fraudulent CV Testing Schemes

The U.S. Department of Health and Human Services' (HHS') Office of Inspector General has issued a consumer alert, urging parents, caregivers, athletic programs and student athletes to beware of fraudulent cardiovascular testing schemes exploiting fears around sudden cardiac arrest in young athletes.

ACC (Cardiology) · Jun 25, 2026

Combined LDL-C, Lp(a) and hsCRP Assessment Identifies Long-Term Risk of ASCVD

Combined assessment of LDL-C, Lp(a) and hsCRP reflected independent pathways for identifying individuals of varied ethnicities at greater long-term risk of atherosclerotic cardiovascular disease (ASCVD), according to an analysis of the HELIUS cohort published June 24 in JACC.

ACC (Cardiology) · Jun 25, 2026

2026 Mid-Year Update on ACC Advocacy Efforts

Throughout the first half of 2026, ACC’s Advocacy Team has been actively engaged in shaping policy at both the federal and state levels and working with policymakers to support cardiovascular clinicians and improve patient care nationwide. Read about key highlights from this work below.

ACC (Cardiology) · Jun 25, 2026

New Risk Score Helps Identify Bleeding Risk With DOACs in Cancer-Associated VTE

The novel ONCO-DOAC BLEED risk score, developed by Tomoyuki Nagai, MD, et al., provided clinically relevant major bleeding risk stratification for patients with cancer-associated venous thromboembolism (VTE) receiving direct oral anticoagulants (DOAC), according to research published June 16 in JACC: CardioOncology.

ACC (Cardiology) · Jun 25, 2026

PARTNER 2A, P2S3i Registry: 10-Year TAVR Outcomes With SAPIEN XT, SAPIEN 3

The rates of mortality and reintervention at 10 years were higher in patients at intermediate risk who underwent TAVR with the second-generation SAPIEN XT valve than those who underwent surgery in the PARTNER 2A trial, according to an analysis published June 16 in a valvular heart disease focus issue of JACC.

ADA (Diabetes) · Jun 24, 2026

New Standards of Care in Overweight and Obesity Section: Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults

New Standards of Care in Overweight and Obesity Section: Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults mcarmody Wed, 06/24/2026 - 17:26 Press release New Standards of Care in Overweight and Obesity Section: Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults ARLINGTON, Va. June 29, 2026 Today, the Obesity Association, a division of the American Diabetes Association ® (the association), announced the next section in the Standards of Care in Overweight and Obesity, “ Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults ,” published in Diabetes…

ACC (Cardiology) · Jun 24, 2026

FXN Gene Therapy Shows Promise in Treating Patients With FA Cardiomyopathy

In patients with Friedreich ataxia (FA) cardiomyopathy, intravenous administration of AAVrh.10hFXN, an rh.10 serotype cardiotropic adenoassociated virus vector expressing the normal human FXN coding sequence, was well tolerated and showed promise as a potential treatment...

ADA (Diabetes) · Jun 24, 2026

The American Diabetes Association’s Statement on Moving Civil Rights and Special Education Services

The American Diabetes Association’s Statement on Moving Civil Rights and Special Education Services mcarmody Wed, 06/24/2026 - 13:58 Official Statement The American Diabetes Association’s Statement on Moving Civil Rights and Special Education Services ARLINGTON, Va. June 24, 2026 In response to the U.S. Department of Education’s recent announcement of its intention to move oversight of civil rights to the U.S. Department of Justice and special education services to the U.S. Department of Health and Human Services, the American Diabetes Association ® (ADA) issued the following statement…

ACC (Cardiology) · Jun 24, 2026

Eagle’s Eye View: Can Resistance Training Lower CV Risk?

In this week’s View, Dr. Eagle reviews 21-year follow-up data from the Diabetes Prevention Program (DPP), showing that lifestyle intervention—but not metformin—reduces multimorbidity risk in prediabetes.

← NewerOlder →

Back to the live front page